YTEN stock: buy or sell?

YTEN stock price: $0.59 -3.28% At close on September 20th, 2019

Updated on:
September 20th, 2019

0

Yield10 Bioscience closed today at $0.59 and slipped a shocking -3.28%. On Tuesday YTEN plunged a dreadful -6.67%.

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States.

Should I buy YTEN stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with Yield10 Bioscience stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean YTEN will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Yield10 Bioscience stock a buy?

Banks and financial institutions post stock ratings everyday. At Stocks2.com, we detected 6 ratings published for YTEN stock in the last 30 days.

The general sentiment of these ratings is bullish for YTEN stock, with 6 positive ratings.
Is YTEN a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-20National Securitiesn/aBuy
2019-8-13National SecuritiesBuyBuy
2019-8-13Aegisn/aBuy
2019-7-22Aegisn/aBuy
2019-3-26Maxim Groupn/aBuy
2019-1-23National Securitiesn/aBuy

YTEN stock analysis

Daily outlook

Yield10 Bioscience shares slipped -3.28% to $0.59 today.

Yield10 Bioscience shares slipped -3.28% to $0.59 today. YTEN marked a lower low and a lower high in the short term, defining a downward trend. Climbing above $0.66 would break this short term down trend and open possibilities for reversing this situation.

YTEN stock chart (daily)

Weekly outlook

Shares of Yield10 Bioscience collapsed a scary -9.23% this week. Early August YTEN skyrocketed a dazzling 9.38% in just one week.

Yield10 Bioscience slid through the support line what triggered further losses.

YTEN stock chart (weekly)

YTEN stock price history

YTEN stock went public on November 10th, 2006 with a price of $855.001. Since then, YTEN stock lost a -99.90%, with a yearly average of -8.30%.

1: Adjusted price after possible price splits or reverse-splits.

YTEN stock historical price chart

YTEN stock reached 52-week highs on March at $1.77, and all-time highs 2007-10-30 with a price of 1785.6.

YTEN stock price target is $4.30

Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' YTEN stock price predictions in the hope that they will be met as they may be wrong and not met. We found 4 price predictions for YTEN stock released in the last month:
YTEN stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-8-13National SecuritiesReiterates$5.00$5.000%
2019-8-13AegisReiteratesn/a$2.00-
2019-3-26Maxim GroupSet Price Targetn/a$5.00-
2019-1-23National SecuritiesInitiatesn/a$5.00-
(in average)$5.00$4.30-14.0%
Moving in a range from $5.00 and $2.00, the price forecast for Yield10 Bioscience stock is $4.30. In average, analysts' outlook on YTEN price forecast is negative, reducing the target by a -14.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

After posting its last earnings report on March, Yield10 Bioscience . Unfortunately, reported EPS is not yet available in our database.
YTEN earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.74n/a
2017-Q2-n/a-0.96n/a
2017-Q3-n/a-0.59n/a
2017-Q42018-03-08n/a-0.99n/a
2018-Q12018-05-10n/a-0.24n/a
2018-Q22018-08-09n/a-0.24n/a
2018-Q32018-11-08n/a-0.26n/a
2018-Q42019-03-25n/a-0.19n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In 2018, Yield10 Bioscience annual sales plummed a hair-raising -41.10% to $0.56 million dollars from $0.94 marked in 2017. Likewise, its earnings margin (compared to revenues) collapsed to -1,649.28%, that is $-9.17 million.

YTEN annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$5.39 M-$-30.51 M-566.0%-
2014$2.80 M-48.05%$-29.53 M-1054.8%-3.20%
2015$2.59 M-7.36%$-23.68 M-912.9%-19.82%
2016$1.16 M-55.32%$-7.60 M-656.1%-67.89%
2017$0.94 M-18.55%$-9.40 M-995.3%23.57%
2018$0.56 M-41.10%$-9.17 M-1649.3%-2.41%

Quarterly financial results

Yield10 Bioscience posted $0.14 M in revenues for 2018-Q4, a 77.63% up compared to previous quarter. Reported quarter income marked $-1.86 M with a profit margin of -1,377.78%. Profit margin skyrocketed a 2,082.75% compared to previous quarter when profit margin was -3,460.53%. When comparing turnover to same quarter last year, Yield10 Bioscience sales marked an outstanding increase and climbed a 29.81%.
YTEN quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q1$0.32 M-$-2.09 M-645.1%-
2017-Q2$0.29 M-9.57%$-2.73 M-931.7%30.62%
2017-Q3$0.22 M-23.89%$-2.03 M-908.1%-25.82%
2017-Q4$0.10 M-53.36%$-2.55 M-2453.8%26.02%
2018-Q1$0.06 M-42.31%$-2.29 M-3816.7%-10.27%
2018-Q2$0.29 M375.00%$-2.39 M-838.6%4.37%
2018-Q3$0.08 M-73.33%$-2.63 M-3460.5%10.04%
2018-Q4$0.14 M77.63%$-1.86 M-1377.8%-29.28%

Yield10 Bioscience ownership

When you are planning to buy shares of a company, it's worth to have a look its ownership structure.

Yield10 Bioscience shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 29.65% of all shares.

In case of Yield10 Bioscience stock, 7.26% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for YTEN stock account 0.00%, no big difference from last month.

For a better understanding, the following table shows ownership data compared to other related companies:

YTENABTADMPOLTSE
Market cap$7.4 M$147.9 B$22.8 B$2.4 B$1.8 B
Total shares12.5 M1,770.0 M557.0 M76.9 M40.2 M
Float shares9.3 M1,750.0 M554.3 M76.0 M39.9 M
  - Institutional holdings (%)7.3%76.5%80.4%95.7%97.5%
  - Insider holdings (%)29.6%0.7%0.3%1.1%0.6%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

YTEN summary

Friday, September 20th, 2019
Open$0.64
Close$0.59
Day range$0.59 - $0.64
Previous close$0.61
Session gain-3.28%
Average true range$0.05
50d mov avg$0.84
100d mov avg$0.88
200d mov avg$0.99
Daily patternlb06a
Weekly pattern lt06c

Yield10 Bioscience performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We selected , Archer-Daniels-Midland, PolyOne, Trinseo and Westlake Chemical as the bechmarking frame for Yield10 Bioscience stock.
Stock3m6m12m
YTENYield10 Bioscienc...-32.18%-52.42%-57.25%
ABT-1.30%8.04%23.06%
ADMArcher-Daniels-Mi...0.49%-2.29%-15.93%
POLPolyOne7.31%11.72%-28.35%
TSETrinseo8.76%1.78%-41.44%
WLKWestlake Chemical-1.60%-0.63%-23.06%

Yield10 Bioscience competitors

We chose a few stocks to conform a list of Yield10 Bioscience competitors to check if you are interested in investing in YTEN: